阿尔茨海默病治疗与预防策略的最新进展。
An update on treatment and prevention strategies for Alzheimer's disease.
作者信息
Neugroschl Judith, Sano Mary
机构信息
James J. Peters Veterans Affairs Medical Center, Bronx, NY 10468, USA.
出版信息
Curr Neurol Neurosci Rep. 2009 Sep;9(5):368-76. doi: 10.1007/s11910-009-0054-1.
Abstract
With the aging of the population, the incidence and prevalence of Alzheimer's disease will grow, increasing the burden on individuals and society. While ameliorating symptoms, the currently available treatments approved by the US Food and Drug Administration do not halt progression or cure the illness. This article discusses recent data on treatment strategies targeting amyloid and tau pathology. Novel therapeutic strategies such as inhibitors of receptors for advanced glycation end products (RAGE), potential mitochondrial modification with Dimebon, anti-inflammatory approaches, and cholesterol-lowering agents are also reviewed. An update on results from pharmacologic and nonpharmacologic prevention trials is provided.
摘要
随着人口老龄化，阿尔茨海默病的发病率和患病率将会上升，这将增加个人和社会的负担。尽管美国食品药品监督管理局批准的现有治疗方法能够缓解症状，但并不能阻止疾病进展或治愈该病。本文讨论了针对淀粉样蛋白和tau蛋白病变的治疗策略的最新数据。还综述了新型治疗策略，如晚期糖基化终末产物受体（RAGE）抑制剂、用二甲金刚胺进行潜在的线粒体修饰、抗炎方法以及降胆固醇药物。本文还提供了药物和非药物预防试验结果的最新情况。
相似文献
1
An update on treatment and prevention strategies for Alzheimer's disease.阿尔茨海默病治疗与预防策略的最新进展。
Curr Neurol Neurosci Rep. 2009 Sep;9(5):368-76. doi: 10.1007/s11910-009-0054-1.
2
Non-cholinergic strategies for treating and preventing Alzheimer's disease.治疗和预防阿尔茨海默病的非胆碱能策略。
CNS Drugs. 2002;16(12):811-24. doi: 10.2165/00023210-200216120-00003.
3
Anti-amyloid treatments in Alzheimer's disease.阿尔茨海默病的抗淀粉样蛋白治疗
Recent Pat CNS Drug Discov. 2009 Jun;4(2):143-8. doi: 10.2174/157488909788453040.
4
Current therapies and new strategies for the management of Alzheimer's disease.阿尔茨海默病的治疗现状和新策略。
Am J Alzheimers Dis Other Demen. 2010 Aug;25(5):414-24. doi: 10.1177/1533317510372372. Epub 2010 Jul 2.
5
Future targeted disease modifying drugs for Alzheimer's disease.未来用于治疗阿尔茨海默病的靶向疾病修饰药物。
Recent Pat CNS Drug Discov. 2011 Jan;6(1):65-76. doi: 10.2174/157488911794079073.
6
Recent therapeutic strategies targeting beta amyloid and tauopathies in Alzheimer's disease.针对阿尔茨海默病中β淀粉样蛋白和tau 病的最新治疗策略。
Brain Res Bull. 2019 Mar;146:171-184. doi: 10.1016/j.brainresbull.2019.01.004. Epub 2019 Jan 8.
7
Amyloid beta peptide immunotherapy in Alzheimer disease.阿尔茨海默病中的β淀粉样肽免疫疗法。
Rev Neurol (Paris). 2014 Dec;170(12):739-48. doi: 10.1016/j.neurol.2014.10.003. Epub 2014 Nov 6.
8
AGE-RAGE stress: a changing landscape in pathology and treatment of Alzheimer's disease.衰老相关的应激：阿尔茨海默病病理和治疗的变化态势。
Mol Cell Biochem. 2019 Sep;459(1-2):95-112. doi: 10.1007/s11010-019-03553-4. Epub 2019 May 11.
9
Current understanding of Alzheimer's disease diagnosis and treatment.阿尔茨海默病诊断与治疗的当前认识
F1000Res. 2018 Jul 31;7. doi: 10.12688/f1000research.14506.1. eCollection 2018.
10
Plasma GFAP is an early marker of amyloid-β but not tau pathology in Alzheimer's disease.血浆 GFAP 是阿尔茨海默病中淀粉样-β但不是 tau 病理学的早期标志物。
Brain. 2021 Dec 16;144(11):3505-3516. doi: 10.1093/brain/awab223.
引用本文的文献
1
The effects of carvacrol and p-cymene on Aβ -induced long-term potentiation deficit in male rats.香芹酚和对伞花烃对雄性大鼠 Aβ 诱导的长时程增强缺陷的影响。
CNS Neurosci Ther. 2024 Mar;30(3):e14459. doi: 10.1111/cns.14459. Epub 2023 Sep 19.
2
Association between dietary vitamin E intake and cognitive decline among old American: National Health and Nutrition Examination Survey.美国老年人膳食维生素E摄入量与认知能力下降之间的关联：美国国家健康与营养检查调查
Eur Geriatr Med. 2023 Oct;14(5):1027-1036. doi: 10.1007/s41999-023-00814-w. Epub 2023 Aug 24.
3
PROTECTIVE EFFECT OF L. IN Β-AMYLOID-INDUCED ANIMAL MODEL OF ALZHEIMER'S DISEASE.罗伊氏乳杆菌在β-淀粉样蛋白诱导的阿尔茨海默病动物模型中的保护作用。
Afr J Tradit Complement Altern Med. 2017 Jun 5;14(4):140-148. doi: 10.21010/ajtcam.v14i4.17. eCollection 2017.
4
Dementia, Preclinical Studies in Neurodegeneration and its Potential for Translational Medicine in South America.痴呆症、神经退行性疾病的临床前研究及其在南美洲转化医学中的潜力。
Front Aging Neurosci. 2016 Dec 20;8:304. doi: 10.3389/fnagi.2016.00304. eCollection 2016.
5
Synthesis and application of β-carbolines as novel multi-functional anti-Alzheimer's disease agents.β-咔啉作为新型多功能抗阿尔茨海默病药物的合成与应用
Bioorg Med Chem Lett. 2017 Jan 15;27(2):232-236. doi: 10.1016/j.bmcl.2016.11.067. Epub 2016 Nov 24.
6
The flavonoid quercetin ameliorates Alzheimer's disease pathology and protects cognitive and emotional function in aged triple transgenic Alzheimer's disease model mice.类黄酮槲皮素可改善阿尔茨海默病病理，并保护老年三重转基因阿尔茨海默病模型小鼠的认知和情感功能。
Neuropharmacology. 2015 Jun;93:134-45. doi: 10.1016/j.neuropharm.2015.01.027. Epub 2015 Feb 7.
7
Tritium-labeled (E,E)-2,5-bis(4'-hydroxy-3'-carboxystyryl)benzene as a probe for β-amyloid fibrils.氚标记的（E，E）-2,5-双（4'-羟基-3'-羧基苯乙烯基）苯作为β-淀粉样蛋白原纤维的探针。
Bioorg Med Chem Lett. 2014 Dec 1;24(23):5534-6. doi: 10.1016/j.bmcl.2014.09.075. Epub 2014 Oct 6.
8
Variation in Variables that Predict Progression from MCI to AD Dementia over Duration of Follow-up.在随访期间，预测从轻度认知障碍进展为阿尔茨海默病痴呆的变量的变化。
Am J Alzheimers Dis (Columbia). 2013;2(1):12-28. doi: 10.7726/ajad.2013.1002.
9
Deep brain stimulation: a novel strategy for treating Alzheimer's disease.深部脑刺激：一种治疗阿尔茨海默病的新策略。
Innov Clin Neurosci. 2012 Nov;9(11-12):10-7.
10
Effects of single doses of avagacestat (BMS-708163) on cerebrospinal fluid Aβ levels in healthy young men.阿伐加他汀（BMS-708163）单次给药对健康年轻男性脑脊液 Aβ 水平的影响。
Clin Drug Investig. 2012 Nov;32(11):761-9. doi: 10.1007/s40261-012-0006-4.
本文引用的文献
1
Risk of dementia and AD with prior exposure to NSAIDs in an elderly community-based cohort.在一个以社区为基础的老年队列中，既往使用非甾体抗炎药（NSAIDs）后患痴呆症和阿尔茨海默病（AD）的风险。
Neurology. 2009 Jun 2;72(22):1899-905. doi: 10.1212/WNL.0b013e3181a18691. Epub 2009 Apr 22.
2
Design, synthesis, and biological evaluation of new 5-HT4 receptor agonists: application as amyloid cascade modulators and potential therapeutic utility in Alzheimer's disease.新型5-羟色胺4受体激动剂的设计、合成及生物学评价：作为淀粉样蛋白级联调节剂的应用及在阿尔茨海默病中的潜在治疗效用
J Med Chem. 2009 Apr 23;52(8):2214-25. doi: 10.1021/jm801327q.
3
Alzheimer's Disease Anti-inflammatory Prevention Trial: design, methods, and baseline results.阿尔茨海默病抗炎预防试验：设计、方法及基线结果
Alzheimers Dement. 2009 Mar;5(2):93-104. doi: 10.1016/j.jalz.2008.09.004.
4
A cognitive training program based on principles of brain plasticity: results from the Improvement in Memory with Plasticity-based Adaptive Cognitive Training (IMPACT) study.一项基于大脑可塑性原理的认知训练计划：基于可塑性的适应性认知训练改善记忆（IMPACT）研究的结果。
J Am Geriatr Soc. 2009 Apr;57(4):594-603. doi: 10.1111/j.1532-5415.2008.02167.x. Epub 2009 Feb 9.
5
Plasma Abeta, homocysteine, and cognition: the Vitamin Intervention for Stroke Prevention (VISP) trial.血浆β淀粉样蛋白、同型半胱氨酸与认知：预防中风的维生素干预（VISP）试验
Neurology. 2009 Jan 20;72(3):268-72. doi: 10.1212/01.wnl.0000339486.63862.db.
6
Ginkgo biloba for prevention of dementia: a randomized controlled trial.银杏叶预防痴呆症：一项随机对照试验。
JAMA. 2008 Nov 19;300(19):2253-62. doi: 10.1001/jama.2008.683.
7
High-dose B vitamin supplementation and cognitive decline in Alzheimer disease: a randomized controlled trial.高剂量B族维生素补充剂与阿尔茨海默病认知功能衰退：一项随机对照试验
JAMA. 2008 Oct 15;300(15):1774-83. doi: 10.1001/jama.300.15.1774.
8
Effect of physical activity on cognitive function in older adults at risk for Alzheimer disease: a randomized trial.体育活动对有患阿尔茨海默病风险的老年人认知功能的影响：一项随机试验。
JAMA. 2008 Sep 3;300(9):1027-37. doi: 10.1001/jama.300.9.1027.
9
Effect of fish oil on cognitive performance in older subjects: a randomized, controlled trial.鱼油对老年受试者认知能力的影响：一项随机对照试验。
Neurology. 2008 Aug 5;71(6):430-8. doi: 10.1212/01.wnl.0000324268.45138.86.
10
Effect of dimebon on cognition, activities of daily living, behaviour, and global function in patients with mild-to-moderate Alzheimer's disease: a randomised, double-blind, placebo-controlled study.二甲金刚胺对轻至中度阿尔茨海默病患者认知、日常生活活动能力、行为及整体功能的影响：一项随机、双盲、安慰剂对照研究
Lancet. 2008 Jul 19;372(9634):207-15. doi: 10.1016/S0140-6736(08)61074-0.
Zotero 插件